Bayer Shares Experience Their Strongest Surge in 17 Years Following Backing from Trump's Solicitor General
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 02 2025
0mins
Source: MarketWatch
Bayer's Share Increase: Bayer shares surged by 15% following support from the U.S. solicitor general for the company's Supreme Court bid to limit litigation over Roundup pesticide's alleged cancer risks.
Litigation Resolution Goals: Analysts believe this backing will aid Bayer in resolving glyphosate-related lawsuits by the end of 2026.
EPA's Stance on Glyphosate: The U.S. Environmental Protection Agency has consistently stated that glyphosate is unlikely to cause cancer in humans.
Approval of Roundup Labels: The EPA has approved Roundup product labels multiple times without including cancer warnings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
